|
|
| 2018, Vol. 27(6): 564-569 DOI: 10.3760/cma.j.issn.1004-4221.2018.06.006 | ||
| Clinical efficacy and safety of randomized phase 2 trial of pemetrexed-cisplatin or docetaxel-cisplatin plus thoracic intensity-modulated radiation therapy in patients with stage IV lung adenocarcinoma | ||
| Li Mei, Geng Yichao, Yang Wengang, Ma Zhu, Li Qingsong, Wang Yu, Luo Daxian, Hu Yinxiang, Ouyang Weiwei, Liu Lingfeng, Su Shengfa, Lu Bing | ||
| Department of Thoracic Oncology, Affiliated Hospital of Guizhou Medical University,Guizhou Cancer Hospital, Teaching and Research Section of Oncology, Guizhou Medical University, Guiyang 550004,China | ||
| Received 2017-03-20 Revised null | ||
| Supporting info | ||
| null | ||
|
